Trimetazidine Induces Parkinsonism, Gait Disorders and Tremor-Reference-Cited by-同舟云学术

Trimetazidine Induces Parkinsonism, Gait Disorders and Tremor

Published:2005-07 Issue:4 Volume:60 Page:419-422
ISSN:0040-5957
Container-title:Therapies
language:en
Short-container-title:Therapies

Author:

Massó José-Félix Martí,Martí Itxaso,Carrera Nieves,Poza Juan-José,de Munain Adolfo López

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference10 articles.

1. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions;McClellan;Drugs,1999

2. Trimetazidine: a second look. Still no efficacy in visual disorders;Prescrire Int,2002

3. Intérêt de vastarel 20mg (trimétazidine) dans le traitement des vertiges;Bouccara;Ann Otolaryngol Chir Cervicofac,1999

4. Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies;Szwed;Coron Artery Dis,2001

5. Parkinson’s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group Italian Longitudinal Study on Aging;Baldereschi;Neurology,2000

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interest of hair tests to discriminate a tail end of a doping regimen from a possible contamination in case of challenging an anti‐doping rule violation. V. Case reports involving trimetazidine, a drug where the concentration after a single 20 mg dose has been established;Drug Testing and Analysis;2024-08

2. Evaluation of the pharmacokinetics, bioequivalence, and safety of two preparations of 20 mg trimetazidine;2024-02-28

3. Effectiveness of Trimetazidine in Patients with Chronic Heart Failure Stratified by the Expression of Soluble Suppression of Tumorigenicity-2 (sST2): A Prospective Cohort Study;Advances in Therapy;2022-10-12

4. The Application of Trimetazidine in Healthy Individuals: A Systematic Review;2022-05-10

5. Trimetazidine Use in Parkinson’s Disease: Is It a Resolved Problem?;eneuro;2021-04-16